Sermorelin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of Sermorelin is 13 minutes (rapid metabolism). This means dosing once daily before bedtime is typical to maintain stable levels. The half-life directly affects how long Sermorelin remains active and influences optimal injection timing.
What Is the Half-Life of Sermorelin?
The half-life of Sermorelin is 13 minutes (rapid metabolism). This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer Sermorelin to maintain therapeutic blood levels.
What Does Sermorelin's Half-Life Mean for Dosing?
With a half-life of 13 minutes (rapid metabolism), Sermorelin requires dosing once daily before bedtime to maintain stable levels. The standard dosage of 200-500 mcg daily via subcutaneous injection accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, Sermorelin reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For Sermorelin, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject Sermorelin?
Optimal timing depends on your research goals. A half-life of 13 minutes (rapid metabolism) means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (once daily before bedtime) for more stable levels throughout the day.
How Does Sermorelin's Half-Life Compare to Similar Peptides?
Sermorelin is a GHRH analog, growth hormone secretagogue. Its half-life of 13 minutes (rapid metabolism) positions it with a shorter duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your Sermorelin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Sermorelin.
Open Calculator →Bottom Line: Sermorelin Half-Life and Dosing
Sermorelin has a half-life of 13 minutes (rapid metabolism), supporting the standard protocol of 200-500 mcg daily dosed once daily before bedtime over 12-24 weeks; adjust after 4-6 weeks based on IGF-1 levels.
Read our Sermorelin dosage guide for complete protocol details.
Complete Guide
Sermorelin : Dosing, Effects & How It Compares to CJC-1295
Related Reading
- Sermorelin Dosage Guide
- Sermorelin Benefits
- Sermorelin Side Effects
- Sermorelin Stacking Guide
- Sermorelin Cycle Guide
- Sermorelin Research
Research-Grade Sourcing
If you're going to research Sermorelin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Sermorelin?
Sermorelin (Growth Hormone-Releasing Hormone analog (GRF 1-29)) is a GHRH analog, growth hormone secretagogue. Synthetic analog of endogenous GHRH (first 29 amino acids) that stimulates natural GH production. It is researched for endogenous GH stimulation, lean mass gain, fat loss, IGF-1 elevation, improved recovery, bone density.
What is the recommended Sermorelin dosage?
Common dosages: 200-500 mcg daily administered once daily before bedtime via subcutaneous injection. Cycle length: 12-24 weeks; adjust after 4-6 weeks based on IGF-1 levels. Half-life: 13 minutes (rapid metabolism). Use our peptide calculator for exact reconstitution math.
What are the side effects of Sermorelin?
Generally well-tolerated. Minor injection site reactions. Transient facial flushing, dizziness, or nausea in early dosing. Minimal systemic effects due to short half-life.
Is Sermorelin safe?
Sermorelin has shown a favorable safety profile in research. Originally FDA-approved (1997). Manufacturer discontinued (2008). Legal off-label through compounding pharmacies. Prescription required. All research should follow appropriate safety protocols.